New insights into YAP/TAZ nucleo‐cytoplasmic shuttling: new cancer therapeutic opportunities?
Yes‐associated protein (YAP) and transcriptional co‐activator with PDZ‐binding motif (TAZ), the main effectors of the Hippo pathway, are emerging as important players in cancer biology and therapy response. The intracellular localization of YAP/TAZ is a key determinant in the regulation of their act...
Main Authors: | Michal Shreberk‐Shaked, Moshe Oren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12498 |
Similar Items
-
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
by: Janine S. A. Warren, et al.
Published: (2018-04-01) -
Roles of Hippo–YAP/TAZ signalling in intervertebral disc degeneration
by: Shi Zheng-wei, et al.
Published: (2023-03-01) -
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
by: Gandhi T. K. Boopathy, et al.
Published: (2019-04-01) -
New insights into the ambivalent role of YAP/TAZ in human cancers
by: Juan Luo, et al.
Published: (2023-05-01) -
YAP/TAZ: a promising target for squamous cell carcinoma treatment
by: Dong X, et al.
Published: (2019-07-01)